JG

John Gomes Saia

Active Director Director DIN 10646611
DIN 10646611 First appointment May 2024 Primary industry Real Estate
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About John Gomes Saia

Data last updated:

John Gomes Saia is a Director at Guardant Health India Private Limited (since 2024). The company operates in Real Estate.

DIN 10646611
Primary Designation Director
Industry Real Estate
First Appointment 28 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20242024Active

Directorship timeline

Open interactive timeline →
Guardant Health India Private Limited
Premium access

Shareholding and investment profile for John Gomes Saia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Gomes Saia

John Gomes Saia currently holds 1 directorship: Guardant Health India Private Limited (Director, since 28 May 2024).

John Gomes Saia was first appointed on 28 May 2024 as Director at Guardant Health India Private Limited.

The current boards of John Gomes Saia's companies include Kumud Kalia (Guardant Health India Private Limited), Michael Brian Bell (Guardant Health India Private Limited), Rohitash Harikrishna Saini (Guardant Health India Private Limited), Simranjit Singh (Guardant Health India Private Limited), Umesh Nellitheertha Vasudeva (Guardant Health India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available